Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis

NARecruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Plantar Fasciitis
Interventions
DRUG

Botulinum toxin A

"Researchers discovered in the 1950s that injecting overactive muscles with minute quantities of botulinum toxin type-A would result in decreased muscle activity. Botulinum toxin type-A has this effect because it prevents the vesicle where the acetylcholine is stored from binding to the membrane where the neurotransmitter can be released. Botulinum toxin type-A thus blocks the release of acetylcholine by the neuron. This will effectively weaken the muscle for a period of three to four months.~In addition to its cosmetic applications, Botox is currently used in the treatment of spasms and dystonias, by weakening involved muscles, for the 60-70 day effective period of the drug. The main conditions treated with botulinum toxin are: Cervical dystonia (spasmodic torticollis) (a neuromuscular disorder involving the head and neck), Blepharospasm (excessive blinking) etc.."

DRUG

cortisone

DRUG

Saline

Trial Locations (2)

3010

RECRUITING

Dep, of Orthopaedic Surgery, Inselspital, University of Berne, Bern

6000

RECRUITING

Department of Orthopaedic Surgery, Kantonsspital Lucerne, Lucerne

All Listed Sponsors
collaborator

Luzerner Kantonsspital

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER